康众医疗
On September 29, Lu Junqun from the Institute for Artificial Intelligence International Governance of Tsinghua University, together with Tao Haiqing, Yu Ning and other representatives from the AI Evolution Lab of Listed Companies, visited CareRay's Suzhou headquarters. Liu Jianqiang, Chairman and General Manager of CareRay, and other company representatives participated in the discussions. The two sides held in-depth discussions on the applications and potential cooperation opportunities of artificial intelligence in primary healthcare, the intelligentization of medical devices, and pet healthcare.
“Designing Machines for AI” to Promote Deep Collaboration Between Imaging Equipment and Intelligent Capabilities
During the discussions, CareRay introduced its development philosophy and technology strategy. Centered on the concept of “designing machines for AI,” the company continues to explore the synergy among core imaging components, intelligent hardware, and AI-assisted applications, enabling artificial intelligence to participate more effectively in image processing, operational assistance, and diagnostic and treatment support, while promoting the continuous iteration of its technical capabilities through real-world medical scenarios.
Three Key Application Areas
In the three key areas of primary healthcare, the intelligentization of medical devices, and pet healthcare, the two sides exchanged views on specific scenarios including image acquisition, AI-assisted analysis, intelligent examination workflows, collaboration between edge and cloud models, and related product applications. They discussed ways to combine technical capabilities with actual product requirements and further communicated on the alignment of relevant technical resources and the potential for cooperation.
Exploring Pragmatic Cooperation Driven by Specific Scenarios
This exchange further deepened both sides' understanding of business needs and technical capabilities. Going forward, the two sides will continue to explore the alignment of technical resources and the feasibility of cooperation around specific scenarios such as primary healthcare, the intelligentization of medical devices, and pet healthcare, with the intention of exploring the transition from conceptual discussions to validation through specific projects. CareRay will continue to uphold its original aspiration of “improving public health” and the concept of “designing machines for AI.” Taking product development and real-world application needs as its starting point, the company will explore the deep integration of medical imaging hardware and artificial intelligence, providing more efficient and intelligent products and services for healthcare and pet healthcare. This exchange was an industry discussion and negotiation, and has no material impact on the company's performance in the short term. The development of artificial intelligence from research and development to industrial implementation still requires validation. Investors are advised to invest rationally.